These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36157452)

  • 1. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
    Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
    Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
    Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
    BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Luteolin as a Potential Drug for Treating Lung Adenocarcinoma with COVID-19 Affection based on Integration Analysis of Pharmacology and Transcriptome.
    Peng P; Li N; Zhang N; Fu X; Peng S; Zhao Y; Ai B
    Curr Med Chem; 2024; 31(33):5432-5447. PubMed ID: 37694790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
    Bai Y; Du Z; Wang L; Lau EHY; Fung IC; Holme P; Cowling BJ; Galvani AP; Krug RM; Meyers LA
    Emerg Infect Dis; 2024 Feb; 30(2):262-269. PubMed ID: 38181800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.
    Wang T; Zhang W; Fang C; Wang N; Zhuang Y; Gao S
    Curr Comput Aided Drug Des; 2024; 20(5):486-500. PubMed ID: 37287284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    Malden DE; Hong V; Lewin BJ; Ackerson BK; Lipsitch M; Lewnard JA; Tartof SY
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(25):830-833. PubMed ID: 35737591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
    Uddin MN; Akter R; Li M; Abdelrahman Z
    Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma.
    Liang X; Chen Y; Fan Y
    Environ Sci Pollut Res Int; 2022 Mar; 29(15):22012-22030. PubMed ID: 34775559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
    Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
    Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M
    Dawood AA
    Adv Med Sci; 2023 Mar; 68(1):1-9. PubMed ID: 36368287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariside II in NSCLC and COVID-19: Network pharmacology and molecular docking study.
    Kong Q; Zhu H; Dong J; Liu B
    J Gene Med; 2024 Jul; 26(7):e3710. PubMed ID: 38967229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
    Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
    Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
    Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.